Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
229.51 -0.72 (-0.31%) 11:19 ET [NYSE]
229.44 x 28 229.60 x 6
Realtime by (Cboe BZX)
229.44 x 28 229.60 x 6
Realtime 228.75 -1.48 (-0.64%) 09:29 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
228.75
Day High
230.82
Open 230.16
Previous Close 230.23 230.23
Volume 222,900 222,900
Avg Vol 1,994,576 1,994,576
Stochastic %K 65.38% 65.38%
Weighted Alpha -5.78 -5.78
5-Day Change +2.23 (+0.98%) +2.23 (+0.98%)
52-Week Range 218.75 - 251.99 218.75 - 251.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,107,088
  • Shares Outstanding, K 287,135
  • Annual Sales, $ 20,178 M
  • Annual Income, $ 1,705 M
  • EBIT $ 2,414 M
  • EBITDA $ 4,700 M
  • 60-Month Beta 0.35
  • Price/Sales 3.30
  • Price/Cash Flow 10.97
  • Price/Book 2.64

Options Overview Details

View History
  • Implied Volatility 21.10% ( -0.55%)
  • Historical Volatility 15.18%
  • IV Percentile 57%
  • IV Rank 42.86%
  • IV High 28.78% on 08/05/24
  • IV Low 15.34% on 11/26/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 180
  • Volume Avg (30-Day) 1,219
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 32,994
  • Open Int (30-Day) 40,846

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.28
  • Number of Estimates 10
  • High Estimate 3.30
  • Low Estimate 3.22
  • Prior Year 3.17
  • Growth Rate Est. (year over year) +3.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.64 +3.80%
on 02/28/25
Period Open: 230.31
235.34 -2.24%
on 03/10/25
-0.25 (-0.11%)
since 02/24/25
3-Month
221.64 +3.80%
on 02/28/25
Period Open: 226.95
251.99 -8.70%
on 02/03/25
+3.11 (+1.37%)
since 12/24/24
52-Week
218.75 +5.17%
on 07/10/24
Period Open: 246.25
251.99 -8.70%
on 02/03/25
-16.19 (-6.57%)
since 03/22/24

Most Recent Stories

More News
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

SOLV : 74.51 (+0.73%)
ZBH : 111.61 (+0.79%)
STE : 223.29 (+1.30%)
BDX : 229.48 (-0.33%)
CNMD : 60.42 (+1.31%)
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

SOLV : 74.51 (+0.73%)
ZBH : 111.61 (+0.79%)
STE : 223.29 (+1.30%)
BDX : 229.48 (-0.33%)
CNMD : 60.42 (+1.31%)
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector?

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

XLV : 147.09 (+0.33%)
BDX : 229.48 (-0.33%)
BAX : 33.44 (+0.75%)
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group

BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group

SOLV : 74.51 (+0.73%)
ZBH : 111.61 (+0.79%)
STE : 223.29 (+1.30%)
BDX : 229.48 (-0.33%)
CNMD : 60.42 (+1.31%)
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)

Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)

SOLV : 74.51 (+0.73%)
ZBH : 111.61 (+0.79%)
STE : 223.29 (+1.30%)
BDX : 229.48 (-0.33%)
CNMD : 60.42 (+1.31%)
3 Reasons to Sell BDX and 1 Stock to Buy Instead

3 Reasons to Sell BDX and 1 Stock to Buy Instead

CRWD : 365.00 (+0.76%)
BDX : 229.48 (-0.33%)
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings

Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings

SOLV : 74.51 (+0.73%)
STE : 223.29 (+1.30%)
BDX : 229.48 (-0.33%)
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals,  has been seeing strong growth momentum across its target markets. Earlier this month, the company posted robust fourth-quarter...

ABT : 127.43 (+0.86%)
BSX : 102.44 (+1.74%)
BDX : 229.48 (-0.33%)
MDT : 90.24 (-0.10%)
Do Options Traders Know Something About BD (BDX) Stock We Don't?

Investors in Becton Dickinson and Company BDX, popularly known as BD, need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $120.00 Put...

BDX : 229.48 (-0.33%)
Do Wall Street Analysts Like Becton, Dickinson and Company Stock?

MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.

$SPX : 5,757.92 (+1.59%)
BDX : 229.48 (-0.33%)
IHI : 60.56 (+1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 235.02
2nd Resistance Point 233.15
1st Resistance Point 231.69
Last Price 229.48
1st Support Level 228.35
2nd Support Level 226.48
3rd Support Level 225.02

See More

52-Week High 251.99
Fibonacci 61.8% 239.29
Fibonacci 50% 235.37
Fibonacci 38.2% 231.45
Last Price 229.48
52-Week Low 218.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals